{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:33:15Z","timestamp":1758040395926,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.amjcard.2023.07.057","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T17:51:24Z","timestamp":1690480284000},"page":"274-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Association of Thiazide Diuretics With Diabetes Progression, Kidney Disease Progression, Cardiovascular Outcomes, and Death Among Patients With Diabetes Who Initiate Statins"],"prefix":"10.1016","volume":"203","author":[{"given":"Hesham","family":"Afify","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ubaldo","family":"Gonzalez-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdo","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishak A.","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.07.057_bib0001","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0002","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke Statistics-2021 update: A report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0003","first-page":"575","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can J Cardiol"},{"unstructured":"US Centers for Disease Control and Prevention. US diabetes survelliance system and diabetes atlas 2019. Available at: https:\/\/www.cdc.gov\/diabetes\/data. Accessed on December 9, 2020.","key":"10.1016\/j.amjcard.2023.07.057_bib0004"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0005","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0006","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jamainternmed.2021.5714","article-title":"Association of statin therapy initiation with diabetes progression: A retrospective matched-cohort study","volume":"181","author":"Mansi","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/dom.13491","article-title":"Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial","volume":"21","author":"Bae","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0008","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1253\/circj.CJ-14-0810","volume":"78","author":"Ogawa","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0009","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0010","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0011","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0012","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.118.11769","article-title":"Macrovasculature and microvasculature at the crossroads between type 2 diabetes mellitus and hypertension","volume":"73","author":"Climie","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0013","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0014","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies","volume":"11","author":"Yoshida","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0962280211403603","article-title":"Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease","volume":"22","author":"Danaei","year":"2013","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0016","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/j.1550-8528.1999.tb00417.x","article-title":"Meta-analysis of the effect of excluding early deaths on the estimated relationship between body mass index and mortality","volume":"7","author":"Allison","year":"1999","journal-title":"Obes Res"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0017","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4088\/JCP.v68n0407","article-title":"Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics","volume":"68","author":"Henderson","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0018","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/diacare.15.8.960","article-title":"Trends in diabetes and diabetic complications, 1980\u20131987","volume":"15","author":"Wetterhall","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0019","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1367\/1539-4409(2001)001<0099:CAQOCF>2.0.CO;2","article-title":"Continuity and quality of care for children with diabetes who are covered by Medicaid","volume":"1","author":"Christakis","year":"2001","journal-title":"Ambul Pediatr"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0020","doi-asserted-by":"crossref","first-page":"m1186","DOI":"10.1136\/bmj.m1186","article-title":"Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study","volume":"369","author":"Pasternak","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0021","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ajkd.2005.04.029","article-title":"Identification of individuals with CKD from Medicare claims data: a validation study","volume":"46","author":"Winkelmayer","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.ajkd.2010.05.013","article-title":"CDC CKD Surveillance Team. Validation of CKD and related conditions in existing data sets: A systematic review","volume":"57","author":"Grams","year":"2011","journal-title":"Am J Kidney Dis"},{"unstructured":"Elixhauser A, Steiner C, Palmer L. Clinical Classifications Software (CCS) for ICD-9-CM Databases and Related Tools from the Healthcare Cost and Utilization Project (HCUP) U.S. Agency for Healthcare Research and Quality, 2012: Appendix A.Available at: http:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccs\/ccs.jsp (Accessed on March 16, 2023)","key":"10.1016\/j.amjcard.2023.07.057_bib0023"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0024","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0026","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2007020199","article-title":"Evaluation of the modification of diet in renal disease study equation in a large diverse population","volume":"18","author":"Stevens","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0027","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1536867X0200200403","article-title":"Estimation of average treatment effects based on propensity scores","volume":"2","author":"Becker","year":"2002","journal-title":"The Stata Journal"},{"unstructured":"27. Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. available at: http:\/\/ideas.repec.org\/c\/boc\/bocode\/s432001.html. 2003. (Accessed on March 15, 2023)","key":"10.1016\/j.amjcard.2023.07.057_bib0028"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0029","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/archinte.166.20.2191","volume":"166","author":"Barzilay","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0030","doi-asserted-by":"crossref","first-page":"f6745","DOI":"10.1136\/bmj.f6745","article-title":"Role of diuretics, beta blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study","volume":"347","author":"Shen","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0031","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(21)01920-6","article-title":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis","volume":"398","author":"Nazarzadeh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0032","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0033","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.114.05122","article-title":"Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis","volume":"65","author":"Olde Engberink","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0034","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1755-5922.2010.00180.x","article-title":"Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT","volume":"29","author":"Glover","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0035","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1161\/CIR.0b013e318279acbf","article-title":"Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations","volume":"126","author":"Whelton","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0036","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/HYPERTENSIONAHA.115.06637","article-title":"Modest salt reduction lowers blood pressure and albumin excretion in impaired glucose tolerance and type 2 diabetes mellitus: A randomized double-blind trial","volume":"67","author":"Suckling","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0037","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0038","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jash.2012.07.004","article-title":"Thiazide diuretics in advanced chronic kidney disease","volume":"6","author":"Agarwal","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0039","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa2110730","article-title":"Chlorthalidone for hypertension in advanced chronic kidney disease","volume":"385","author":"Agarwal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.07.057_bib0041","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10157-021-02153-1","article-title":"Calcium channel blocker in patients with chronic kidney disease","volume":"26","author":"Ohno","year":"2022","journal-title":"Clin Exp Nephrol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923005830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923005830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:49:34Z","timestamp":1757573374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923005830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":41,"alternative-id":["S0002914923005830"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.07.057","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Thiazide Diuretics With Diabetes Progression, Kidney Disease Progression, Cardiovascular Outcomes, and Death Among Patients With Diabetes Who Initiate Statins","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.07.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}